TRIPS-leping ja elutähtsate ravimite kättesaadavus - kas TRIPS-leping takistab ravimite kättesaadavust?
| dc.contributor.advisor | Kalvi, Anne, juhendaja | |
| dc.contributor.author | Raudsepp, Inga | |
| dc.date.accessioned | 2026-09-02T10:14:04Z | |
| dc.date.available | 2026-09-02T10:14:04Z | |
| dc.date.issued | 2009 | |
| dc.description.uri | https://www.ester.ee/record=b4013520*est | |
| dc.identifier.other | ARH Diss. B-24427 | |
| dc.identifier.uri | https://hdl.handle.net/10062/124055 | |
| dc.language.iso | et | |
| dc.publisher | Tartu Ülikool | |
| dc.subject | bakalaureusetööd | |
| dc.subject | intellektuaalne omand | |
| dc.subject | tööstusomand | |
| dc.subject | rahvusvahelised lepingud | |
| dc.subject | ravimid | |
| dc.subject | patendid | |
| dc.subject | ravimite | |
| dc.subject | kättesaadavus | |
| dc.subject | kaubandus | |
| dc.subject | hinnad | |
| dc.title | TRIPS-leping ja elutähtsate ravimite kättesaadavus - kas TRIPS-leping takistab ravimite kättesaadavust? | |
| dc.type | Thesis |
Failid
Originaal pakett
1 - 1 1